Fosfomycin Etest for Enterobacteriaceae: Interobserver and interlaboratory agreement

被引:17
作者
van Mens, S. P. [1 ,2 ]
ten Doesschate, T. [3 ]
Kluytmans-van den Bergh, M. F. Q. [3 ,4 ,5 ]
Mouton, J. W. [6 ]
Rossen, J. W. A. [7 ]
Verhulst, C. [8 ]
Bonten, M. J. M. [8 ,9 ]
Kluytmans, J. A. J. W. [3 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
[2] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[3] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Univ Med Ctr Utrecht, Heidelberglaan 100, NL-3508 AB Utrecht, Netherlands
[4] Amphia Acad Infect Dis Fdn, Amphia Hosp, Breda, Netherlands
[5] Amphia Hosp, Dept Infect Control, Breda, Netherlands
[6] Univ Rotterdam, Erasmus Med Ctr, Rotterdam, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands
[8] Amphia Hosp, Microvida Lab Microbiol, Breda, Netherlands
[9] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
Etest; Fosfomycin; Antimicrobial susceptibility testing; Enterobacteriaceae; KLEBSIELLA-PNEUMONIAE; SUSCEPTIBILITY;
D O I
10.1016/j.ijantimicag.2018.06.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The increasing use of fosfomycin requires reliable susceptibility testing in clinical practice. The reference standard, agar dilution (AD), is rarely used in routine settings. The fosfomycin Etest (BioMerieux) is frequently used, although reading MICs can be hampered by the interpretation of the growth of macrocolonies in the inhibition zone. We investigated the interobserver (IO), interlaboratory (IL), and interobserver-interlaboratory (IOIL) agreement of the fosfomycin Etest and evaluated the agreement with AD. Methods: Etests were performed for 57 extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae of four bacterial species (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Enterobacter cloacae) in two laboratories. Photographs of fosfomycin Etests were interpreted by four observers following manufacturer's instructions. Results: Essential agreement (EA) and categorical agreement (CA) between Etest and AD were 57% and 89% (kappa-value 0.68), respectively, with an underestimation of Etest interpretations compared with AD of 0.26 (95% confidence interval [CI] 0.03-0.48) 2-fold dilutions. Between Etest observations, IO-EA and -CA were reached in 82% and 94% of comparisons; IL-EA and -CA in 38% and 85% of comparisons; and IOIL-EA and -CA in 40% and 85% of comparisons, respectively. Agreement of the Etest with AD and between Etests was better for E. coli than for other species. Ignoring all macrocolonies and haze during Etest interpretation improved the agreement with AD (CA kappa-value 0.80) and between Etests (CA kappa-value from 0.68 to 0.81). Conclusions: In this study on 57 ESBL-producing Enterobacteriaceae, IOIL agreement was low with an EA of 40% and a CA of 85%, affected most by IL agreement and to a lesser extent by IO agreement. (C) 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:678 / 681
页数:4
相关论文
共 11 条
[1]  
Clinical and Laboratory Standards Institute, 2017, PERF STAND ANT SUSC
[2]   In vitro activity of fosfomycin against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Comparison of susceptibility testing procedures [J].
de Cueto, M ;
López, L ;
Hernández, JR ;
Morillo, C ;
Pascual, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :368-370
[3]  
FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
[4]   PHOSPHONOMYCIN, A NEW ANTIBIOTIC PRODUCED BY STRAINS OF STREPTOMYCES [J].
HENDLIN, D ;
STAPLEY, EO ;
JACKSON, M ;
WALLICK, H ;
MILLER, AK ;
WOLF, FJ ;
MILLER, TW ;
CHAIET, L ;
KAHAN, FM ;
FOLTZ, EL ;
WOODRUFF, HB .
SCIENCE, 1969, 166 (3901) :122-&
[5]   Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates [J].
Hirsch, Elizabeth B. ;
Raux, Brian R. ;
Zucchi, Paola C. ;
Kim, Yisu ;
McCoy, Christopher ;
Kirby, James E. ;
Wright, Sharon B. ;
Eliopoulos, George M. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (06) :642-647
[6]   Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany [J].
Kaase, Martin ;
Szabados, Florian ;
Anders, Agnes ;
Gatermann, Soeren G. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (06) :1893-1897
[7]   Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli [J].
Klontz, Erik H. ;
Tomich, Adam D. ;
Gunther, Sebastian ;
Lemkul, Justin A. ;
Deredge, Daniel ;
Silverstein, Zach ;
Shaw, JoAnna F. ;
McElheny, Christi ;
Doi, Yohei ;
Wintrode, Patrick L. ;
MacKerell, Alexander D., Jr. ;
Sluis-Cremer, Nicolas ;
Sundberg, Eric J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
[8]   Whole-Genome Multilocus Sequence Typing of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae [J].
Kluytmans-van den Bergh, Marjolein F. Q. ;
Rossen, John W. A. ;
Bruijning-Verhagen, Patricia C. J. ;
Bonten, Marc J. M. ;
Friedrich, Alexander W. ;
Vandenbroucke-Grauls, Christina M. J. E. ;
Willems, Rob J. L. ;
Kluytmans, Jan A. J. W. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (12) :2919-2927
[9]   Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae [J].
Lopez-Cerero, Lorena ;
de Cueto, Marina ;
Diaz-Guerrero, Miguel Angel ;
Morillo, Concepcion ;
Pascual, Alvaro .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :810-812
[10]   MIC-based dose adjustment: facts and fables [J].
Mouton, Johan W. ;
Muller, Anouk E. ;
Canton, Rafael ;
Giske, Christian G. ;
Kahlmeter, Gunnar ;
Turnidge, John .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) :564-568